DrugDashboards

Market view

mefenamic acid · Powder

14 marketed package NDCs · 6 active manufacturers

Most dispensed: 250 mg · Capsule · #30 capsules/bottle

The short version

6 companies supply this market — a reasonable cushion if one runs into trouble.

What changed in the last 90 days

Every detected change for mefenamic acid, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

  • Mefenamic AcidAug 19, 2026
    Price up
    NADAC $0.92205 → $0.93331 per unit (+1.22%)
  • Mefenamic acidAug 19, 2026
    Price up
    NADAC $0.92205 → $0.93331 per unit (+1.22%)
  • Mefenamic AcidJul 22, 2026
    Price down
    NADAC $0.95897 → $0.92205 per unit (-3.85%)
  • Mefenamic acidJul 22, 2026
    Price down
    NADAC $0.95897 → $0.92205 per unit (-3.85%)

Same drug class

Other molecules FDA puts in Nonsteroidal Anti-inflammatory Drug, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Mefenamic acid in shortage right now?
No. FDA does not currently list Mefenamic acid in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
Who makes Mefenamic acid?
12 companies have marketed Mefenamic acid in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
What does Mefenamic acid cost?
The typical pharmacy pays about $0.9333 per unit, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.